Egon Zehnder
Search
Select region
Close filter

Marie Grønnegaard Christensen

Contact Details

+45 33 11 13 53

Marie Grønnegaard Christensen is a leader in Egon Zehnder’s Nordic Healthcare practice, and a member of the London Healthcare team. She is active across all healthcare sectors in the space. She brings deep expertise in the pharmaceutical, biotech and med tech industries and is a core member of Egon Zehnder’s Global Health Practice. Based in Copenhagen and London, she advises clients on the entire C-suite as well as on Board of Director level. Further, Marie has expertise in succession planning at the C-suite and beyond. Leveraging her background in strategy and finance, Marie supports organizations to harness their strategic and operational goals in evolving markets. Marie is also active in the Financial Officers and Executive Assessment and Development practices.

It is a luxury to interact with talented leaders and ambitious companies. As I endeavor to understand their context and strategic objectives, I always strive to deliver a bit more than they ask for.

Prior to joining Egon Zehnder, Marie was Vice President of Corporate Strategy at Novo Nordisk. She started her career within Corporate Treasury, and has held leadership positions in finance, strategy, operations, and treasury controlling at the company.

Marie has an MSc in finance and economics from the University of Copenhagen. Further, she holds 2 BA degrees; one in finance and economics, and one in English, both from the University of Aarhus in Denmark. She has also studied at SUNY Binghamton in New York and Nebraska Wesleyan University. She is the mother of twins and enjoys running marathons and relaxing at her family’s second home in northern Italy.

My Areas of Focus

Get in touch
Send Marie a Message
Browse all
Thought Leadership

Thought Leadership by Marie Grønnegaard Christensen

Biotech During a Pandemic: Addressing Challenges Along the Pharma Value Chain

Biotech During a Pandemic: Addressing Challenges Along the Pharma Value Chain

Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic: people are becoming much more comfortable and efficient at… Read more

European Biotech CEOs Navigate Towards a “New Normal

European Biotech CEOs Navigate Towards a “New Normal" Pt 2

Highlights from the fourth round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

Coronavirus – Learnings and Takeaways from Small Biotech

Coronavirus – Learnings and Takeaways from Small Biotech

Highlights from the second round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

European Biotech CEOs Navigate Towards a “New Normal” Pt 1

European Biotech CEOs Navigate Towards a “New Normal” Pt 1

Highlights from the third round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

Discussions with European Biotechs—Bringing Purpose in a Time of Crisis

Discussions with European Biotechs—Bringing Purpose in a Time of Crisis

On April 8 and 9 Egon Zehnder virtually convened a number of biotech board directors to discuss some of the challenges being faced by… Read more

A Global Conversation About HR

A Global Conversation About HR

A 5-part report on how HR leaders can reshape the future of the function. Read more

Related Experts Around the Globe

Sarah Van Dyck

Sarah Van Dyck

San Francisco

Sarah Van Dyck leads Egon Zehnder’s US Consumer Practice and is a core member of the Chief Marketing and Digital Practices. Based in San… Read more

Richard Lehtola

Richard Lehtola

Helsinki

Richard Lehtola, Egon Zehnder’s Managing Partner in Helsinki, advises public companies, family businesses, and private equity firms on CEO succession… Read more

Jill Ader

Jill Ader

Zurich, London

Jill Ader is the Chairwoman of Egon Zehnder, where she has held several global leadership roles over the past decade. Read more

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top